Cinnamon spice comes from the bark of trees in the genus Cinnamomum. This genus has over 300 species distributed in tropical and subtropical regions of North America, Central America, South America, Asia, Oceania, and Australia. There are two notable species from which most commercial cinnamon is harvested. Cinnamomum cassia is the most investigated species for potential benefits and diabetes care, and cassia extract is slightly more efficacious than using the ground bark of C. cassia.
Cinnulin PF® Cinnamon extract, from Cinnamomum cassia, is used in webber naturals Cinnamon Extract, and is ideal for pre-diabetics and type 2 diabetics. Adding this form of cinnamon to your daily regimen may help increase insulin sensitivity especially in cases of type 2 diabetes, and it may help reduce health risks associated with diabetes, including cardiovascular disease.
The patented method used to produce Cinnulin PF extracts, the water-soluble type-A polymers from cinnamon while leaving behind fat-soluble compounds, which can be harmful in higher quantities. This enables the production of an ultra-potent cinnamon extract that is highly effective, yet free of harmful side effects.
Each softgel contains:
CinnamonRich® Cinnamon 20:1 Extract (Cinnamomum cassia) (bark)......... 150 mg
Derived from 3000 mg of cinnamon bark
Non-medicinal ingredients: Rice starch, gelatin capsule (gelatin, purified water), vegetable grade magnesium stearate (lubricant).
Use 1 capsule daily or as directed by a physician.
Exposure to cinnamaldehyde from C. cassia is contraindicated in patients receiving antiplatelet medications. There is a theoretical concern that cinnamaldehyde in the oil portion of C. cassia could potentiate anti-platelet medications. Cinnamaldehyde has been reported to inhibit in vitro aggregation in human and rabbit platelets, but little is known about the anti-thrombotic activities of cinnamaldehyde in vivo [Huan et al, 2006]. Huang et al have demonstrated that cinnamaldehyde can inhibit collagen-induced and thrombin-induced platelet aggregation in vitro in a concentration-dependent manner. In mice, cinnamaldehyde is able to markedly prolonged hemorrhage and coagulation times and effectively reduce the mortality rate of collagen-epinephrine-iinduced acute pulmonary thromboembolism. Cinnamaldehyde can also significantly inhibit collagen-induced platelet aggregation in the rat platelet-rich plasma (PRP). Use of this product at its recommended amounts during pregnancy or during the time of nursing is contraindicated since the full implications to the fetus or to the newborn are not known.
Caution: While judicious use of cinnamon with insulin therapy may provide better control in insulin treated Type 2 diabetes, and in Type
1 diabetic patients with significant insulin resistance, caution is required. Not enough practical information is available to know
how to recommend such use without physician guidance.
Suggested Usage: 1 capsule daily or as directed by a health practitioner